NCT00003035View on ClinicalTrials.gov

Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 1997

Primary Completion Date

June 30, 2001

Study Completion Date

June 30, 2001

Conditions
Breast Cancer
Interventions
BIOLOGICAL

filgrastim

DRUG

doxorubicin hydrochloride

DRUG

paclitaxel

DRUG

tamoxifen citrate

PROCEDURE

surgical procedure

RADIATION

radiation therapy

Trial Locations (1)

20007

Lombardi Cancer Center, Washington D.C.

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Georgetown University

OTHER